iCAD announced commercial availability of ProFound Cloud. The Software-as-a-Service, SaaS, platform provides medical providers with a cost-effective, secure, and scalable means to access and deploy the latest ProFound Breast Health Suite of AI solutions. “With the commercial launch of ProFound Cloud, iCAD is enabling interoperability and access to Breast AI Solutions at enterprise scale, revolutionizing global access to cutting-edge AI solutions in breast health,” said Dana Brown, president, and CEO of iCAD. “Through the power of the cloud and our partnership with Google, we empower medical providers to enhance patient outcomes by helping detect cancer earlier.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICAD:
- iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
- iCAD releases enhanced ProFound Detection workstation
- iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
- iCAD highlights scientific presentations at ECR annual meeting
- iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
